Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline

https://www.businesswire.com/news/home/20210303005275/en/Caribou-Biosciences-Raises-115M-Series-C-Financing-to-Advance-Next-Generation-CRISPR-Technologies-and-Allogeneic-Cell-Therapy-Pipeline
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.